Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia

被引：0
|
作者：
Hannah A. Blair
机构：
[1] Springer,
来源：
Drugs | 2018年 / 78卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original article has been corrected.
引用
收藏
页码：1911 / 1911
相关论文
共 50 条
  • [31] Results of a randomised comparison of oral etoposide, thioguanine and idarubicin (ETI) with thioguanine, cytarabine and daunorubicin (TAD) in elderly patients with acute myeloid leukaemia
    Ruutu, T
    Almqvist, A
    Hallman, H
    Honkanen, T
    Jarvenpaa, E
    Jarventie, G
    Koistinen, P
    Koivunen, E
    Lahtinen, R
    Lehtinen, M
    Nousiainen, T
    Pelliniemi, TT
    Rajamaki, A
    Remes, K
    Sarkkinen, R
    Sinisalo, M
    Timonen, T
    Volin, L
    Elonen, E
    ORAL CYTOTOXIC TREATMENT IN HAEMATOLOGICAL MALIGNANCIES, 1996, 18 (03): : 53 - 59
  • [32] Mathematical models for cytarabine-derived myelosuppression in acute myeloid leukaemia
    Jost, Felix
    Schalk, Enrico
    Rinke, Kristine
    Fischer, Thomas
    Sager, Sebastian
    PLOS ONE, 2019, 14 (07):
  • [33] Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia
    Longu, Francesco
    Fozza, Claudio
    Dessi, Laura
    Longinotti, Maurizio
    Bonfigli, Silvana
    Careddu, Maria Grazia
    Coppola, Lorenzo
    Giannico, Domenica Barbara
    Nieddu, Rosa Maria
    Podda, Luigi
    Pardini, Simonetta
    Dore, Fausto
    Dore, Simone
    Sotgiu, Giovanni
    ACTA HAEMATOLOGICA, 2017, 137 (01) : 15 - +
  • [34] Cost-Effectiveness of Liposomal Cytarabine-Daunorubicin (CPX-351) Compared to Conventional Cytarabine-Daunorubicin Chemotherapy in Acute Myeloid Leukemia
    Bewersdorf, Jan Philipp
    Goshua, George
    Patel, Kishan K.
    Shallis, Rory M.
    Podoltsev, Nikolai
    Huntington, Scott F.
    Zeidan, Amer M.
    BLOOD, 2021, 138
  • [35] DAUNORUBICIN IN ACUTE MYELOCYTIC LEUKAEMIA
    MALPAS, JS
    SCOTT, RB
    LANCET, 1969, 1 (7592): : 469 - &
  • [36] Acute myeloid leukaemia in the elderly: a review
    Pollyea, Daniel A.
    Kohrt, Holbrook E.
    Medeiros, Bruno C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 152 (05) : 524 - 542
  • [37] Cost-effectiveness of gemtuzumab ozogamicin in combination with standard of care chemotherapy (daunorubicin and cytarabine) for first-line treatment of acute myeloid leukaemia
    Mokgokong, R.
    Mamolo, C.
    Cappelleri, J.
    Knight, C.
    Brockbank, J.
    Cawson, M.
    Dombret, H.
    Castaigne, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 43 - 44
  • [38] A Child with Acute Myeloid Leukaemia Complicated by Calcaneal Osteomyelitis due to Atypical Mycobacterial Infection after Induction Chemotherapy with Mitoxantrone, Etoposide, Cytarabine and Daunorubicin
    Chan, W.
    Lee, P.
    Chiang, A.
    Cheuk, D.
    Chan, G.
    Ha, Y.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S501 - S502
  • [39] Outpatient Administration of Liposomal Daunorubicin and Cytarabine (Vyxeos) in Patients With Secondary Acute Myeloid Leukemia
    Kasner, Margaret T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 604 - 606
  • [40] Disposition of Liposomal Daunorubicin During Cotreatment with Cytarabine in Patients with Leukaemia
    Federico Pea
    Domenico Russo
    Mariagrazia Michieli
    Daniela Damiani
    Renato Fanin
    Angela Michelutti
    Teresa Michelutti
    Stefano Piccolrovazzi
    Michele Baccarani
    Mario Furlanut
    Clinical Pharmacokinetics, 2003, 42 : 851 - 862
12345